Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide

International Archives of Allergy and Immunology

Volumn 150, Issue 2, 2009, Pages 144-155

  Triggiani, Massimo ^a   Granata, Francescopaolo ^a   Petraroli, Angelica ^a   Loffredo, Stefania ^a   Frattini, Annunziata ^a   Staiano, Rosaria Ilaria ^a   Monaco, Guglielmo ^b   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

Budesonide; Cytokines; Macrophages; Secretory phospholipases A2

Indexed keywords

ARACHIDONIC ACID; BETA GLUCURONIDASE; BUDESONIDE; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SECRETORY PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INCUBATION TIME; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ARACHIDONIC ACID; BUDESONIDE; CYCLOHEXIMIDE; CYTOKINES; DACTINOMYCIN; GENE EXPRESSION; GLUCURONIDASE; GROUP IA PHOSPHOLIPASES A2; GROUP X PHOSPHOLIPASES A2; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MACROPHAGES, ALVEOLAR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A2, SECRETORY; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65549166493     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218117     Document Type: Article

References (51)

1. Kudo I, Murakami M: Phospholipase A 2 enzymes. Prostaglandins Other Lipid Mediat 2002; 68-69: 3-58.
2. Murakami M, Kudo I: Secretory phospholipase A 2 . Biol Pharm Bull 2004; 27: 1158-1164.
3. Schaloske RH, Dennis EA: The phospholipase A 2 superfamily and its group numbering system. Biochim Biophys Acta 2006; 1761: 1246-1259.
4. Uhl W, Nevalainen TJ, Buchler MW: Phospholipase A 2 : Basic and Clinical Aspects in Inflammatory Diseases. Basel, Karger, 1997.
5. Samet JM, Madden MC, Fonteh AN: Characterization of a secretory phospholipase A 2 in human bronchoalveolar lavage fluid. Exp Lung Res 1996; 22: 299-315.
6. Yamashita JI, Ogawa M, Shirakusa T: Increased expression of membrane-associated phospholipase A 2 in the lower respiratory tract of asymptomatic cigarette smokers. Respir Med 1996; 90: 479-483.
7. Benfield TL, van Steenwijk R, Nielsen TL, Dichter JR, Lipschik GY, Jensen BN, Junge J, Shelhamer JH, Lundgren JD: Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia. Respir Med 1995; 89: 285-290.
8. Kim DK, Fukuda T, Thompson BT, Cockrill B, Hales C, Bonventre JV: Bronchoalveolar lavage fluid phospholipase A 2 activities are increased in human adult respiratory distress syndrome. Am J Physiol 1995; 269: L109-L118.
9. Sorensen J, Kald B, Tagesson C, Lindahl M: Platelet-activating factor and phospholipase A 2 in patients with septic shock and trauma. Intensive Care Med 1994; 20: 555-561.
10. Bowton DL, Seeds MC, Fasano MB, Goldsmith B, Bass DA: Phospholipase A 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med 1997; 155: 421-425.
11. Chilton FH, Averill FJ, Hubbard WC, Fonteh AN, Triggiani M, Liu MC: Antigen-induced generation of lyso-phospholipids in human airways. J Exp Med 1996; 183: 2235-2245.
12. Stadel JM, Hoyle K, Naclerio RM, Roshak A, Chilton FH: Characterization of phospholipase A 2 from human nasal lavage. Am J Respir Cell Mol Biol 1994; 11: 108-113.
13. Masuda S, Murakami M, Mitsuishi M, Komiyama K, Ishikawa Y, Ishii T, Kudo I: Expression of secretory phospholipase A 2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem J 2005; 387: 27-38.
14. Liu Z, Lu X, Wang H, You XJ, Gao QX, Cui YH: Group II subfamily secretory phospholipase A 2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps. Allergy 2007; 62: 999-1006.
15. Triggiani M, Granata F, Giannattasio G, Marone G: Secretory phospholipases A 2 in inflammatory and allergic diseases: not just enzymes. J Allergy Clin Immunol 2005; 116: 1000-1006.
16. Jo EJ, Lee HY, Lee YN, Kim JI, Kang HK, Park DW, Baek SH, Kwak JY, Bae YS: Group IB secretory phospholipase A 2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappaB in human neutrophils. J Immunol 2004; 173: 6433-6439.
17. Park DW, Kim JR, Kim SY, Sonn JK, Bang OS, Kang SS, Kim JH, Baek SH: Akt as a mediator of secretory phospholipase A 2 receptor- involved inducible nitric oxide synthase expression. J Immunol 2003; 170: 2093-2099.
18. Triggiani M, Granata F, Balestrieri B, Petraroli A, Scalia G, Del Vecchio L, Marone G: Secretory phospholipases A 2 activate selective functions in human eosinophils. J Immunol 2003; 170: 3279-3288.
19. 2. Biochim Biophys Acta 2006; 1761: 1289-1300. (Pubitemid 44738703)
20. Triggiani M, Granata F, Oriente A, De Marino V, Gentile M, Calabrese C, Palumbo C, Marone G: Secretory phospholipases A 2 induce β-glucuronidase release and IL-6 production from human lung macrophages. J Immunol 2000; 164: 4908-4915.
21. Granata F, Frattini A, Loffredo S, Del Prete A, Sozzani S, Marone G, Triggiani M: Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A 2 in human lung macrophages. Eur J Immunol 2006; 36: 1938-1950.
22. Granata F, Petraroli A, Boilard E, Bezzine S, Bollinger J, Del Vecchio L, Gelb MH, Lambeau G, Marone G, Triggiani M: Activation of cytokine production by secreted phospholipase A 2 in human lung macrophages expressing the M-type receptor. J Immunol 2005; 174: 464-474.
23. Lohmann-Matthes ML, Steinmuller C, Franke-Ullmann G: Pulmonary macrophages. Eur Respir J 1994; 7: 1678-1689.
24. National Asthma Education and Prevention Program: Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics 2002. J Allergy Clin Immunol 2002; 110:S141-S219.
25. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
26. Riccardi C, Bruscoli S, Migliorati G: Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacol Res 2002; 45: 361-368.
27. Goppelt-Struebe M: Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem Pharmacol 1997; 53: 1389-1395.
28. van der Helm HA, Aarsman AJ, Janssen MJ, Neys FW, van den Bosch H: Regulation of the expression of group IIA and group V secretory phospholipases A 2 in rat mesangial cells. Biochim Biophys Acta 2000; 1484: 215-224.
29. Hidi R, Vargaftig BB, Touqui L: Increased synthesis and secretion of a 14-kDa phospholipase A 2 by guinea pig alveolar macrophages. Dissociation from arachidonic acid liberation and modulation by dexamethasone. J Immunol 1993; 151: 5613-5623.
30. Triggiani M, Oriente A, Marone G: Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. J Immunol 1994; 152: 1394-1403.
31. Triggiani M, Petraroli A, Loffredo S, Frattini A, Granata F, Morabito P, Staiano RI, Secondo A, Annunziato L, Marone G: Differentiation of monocytes into macrophages induces the upregulation of histamine H 1 receptor. J Allergy Clin Immunol 2007; 119: 472-481.
32. Russo-Marie F: Macrophages and the glucocorticoids. J Neuroimmunol 1992; 40: 281-286.
33. Atsuta J, Plitt J, Bochner BS, Schleimer RP: Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am J Respir Cell Mol Biol 1999; 20: 643-650. (Pubitemid 129495652)
34. Stellato C, Matsukura S, Fal A, White J, Beck LA, Proud D, Schleimer RP: Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 1999; 163: 5624-5632.
35. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fey MF: Glucocorticoids downregulate gene expression of GM-CSF, NAP- 1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992; 79: 45-51.
36. Goulding NJ: The molecular complexity of glucocorticoid actions in inflammation: a four-ring circus. Curr Opin Pharmacol 2004; 4: 629-636.
37. Carter AB, Monick MM, Hunninghake GW: Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 1999; 20: 751-758.
38. Szefler SJ, Eigen H: Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. J Allergy Clin Immunol 2002; 109: 730-742.
39. Ek A, Larsson K, Siljerud S, Palmberg L: Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. Allergy 1999; 54: 691-699. (Pubitemid 29333609)
40. Granata F, Balestrieri B, Petraroli A, Giannattasio G, Marone G, Triggiani M: Secretory phospholipases A 2 as multivalent mediators of inflammatory and allergic disorders. Int Arch Allergy Immunol 2003; 131: 153-163.
41. Fonteh AN, Marion CR, Barham BJ, Edens MB, Atsumi G, Samet JM, High KP, Chilton FH: Enhancement of mast cell survival: a novel function of some secretory phospholipase A 2 isotypes. J Immunol 2001; 167: 4161-4171.
42. Steer JH, Kroeger KM, Abraham LJ, Joyce DA: Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J Biol Chem 2000; 275: 18432-18440.
43. Ray A, LaForge KS, Sehgal PB: On the mechanism for efficient repression of the interleukin- 6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol 1990; 10: 5736-5746.
44. Neta R, Sayers TJ, Oppenheim JJ: Relationship of TNF to interleukins. Immunol Ser 1992; 56: 499-566.
45. Horwood NJ, Page TH, McDaid JP, Palmer CD, Campbell J, Mahon T, Brennan FM, Webster D, Foxwell BM: Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J Immunol 2006; 176: 3635-3641.
46. Silliman CC, Moore EE, Zallen G, Gonzalez R, Johnson JL, Elzi DJ, Meng X, Hanasaki K, Ishizaki J, Arita H, Ao L, England KM, Banerjee A: Presence of the M-type sPLA 2 receptor on neutrophils and its role in elastase release and adhesion. Am J Physiol Cell Physiol 2002; 283:C1102-C1113.
47. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC: Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001; 20: 7108-7116.
48. Pelaia G, Gallelli L, D'Agostino B, Vatrella A, Cuda G, Fratto D, Renda T, Galderisi U, Piegari E, Crimi N, Rossi F, Caputi M, Costanzo FS, Vancheri C, Maselli R, Marsico SA: Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts. J Cell Physiol 2007; 210: 489-497.
49. Alessi DR, Smythe C, Keyse SM: The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 1993; 8: 2015-2020.
50. Bowton DL, Dmitrienko AA, Israel E, Zeiher BG, Sides GD: Impact of a soluble phospholipase A 2 inhibitor on inhaled allergen challenge in subjects with asthma. J Asthma 2005; 42: 65-71.
51. Bradley JD, Dmitrienko AA, Kivitz AJ, Gluck OS, Weaver AL, Wiesenhutter C, Myers SL, Sides GD: A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A 2 , in the treatment of rheumatoid arthritis. J Rheumatol 2005; 32: 417-423.